comprehensive -WSS

comprehensive

author：Wikipedia 2025-10-02 22:23:46 - browse：99

Launching your first clinical trial is the type of announcement most biotech executives eagerly anticipate, hoping to celebrate with employees. But for Celsius Therapeutics CEO Tariq Kassum, it’s proving to be more difficult than he anticipated.

That’s because in recent days, Celsius, based in Cambridge, Mass., has been forced to conduct a round of layoffs, sources told STAT. Kassum confirmed around 75% of Celsius’ 40-person team had been laid off, and disclosed that the biotech has also been quietly paring back its pipeline this year. It shut down almost all early-stage research projects, including pausing all of its cancer drug work, in order to conserve enough cash for the Phase 1 trial it announced this week.

“It’s an incredibly bittersweet moment.… The cognitive dissonance there is just really, really hard,” Kassum told STAT. “But I do think that you’re seeing a lot of other companies doing what we are, which is, as painful as it is, to focus on the nearest term value drivers, the things that can get to patients the quickest, and make the painful decisions that allow you to live to fight another day.”

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： Bright Health sells Medicare Advantage business to Molina
Next article： Detailed data confirm benefits, risks of Eli Lilly's Alzheimer's drug

entertainment

WSS

Custom gene therapy hints at new path for rare disease treatments

Doctors find melanoma drugs effective against rare brain cancer

Fauci's latest grilling in Congress: 9 hours, behind closed doors

Medicare to cover more brain scans for Alzheimer’s patients

Biden tests positive for Covid

Listen: Wegovy in the brain & pivotal Alzheimer's data

leisure time

comprehensive

focus

What does generative AI mean for health care? We asked experts

As digital health tech proliferates, a new institute aims to cut through hype

Medicare proposal to cover medical devices draws a mixed reaction

Biden tests positive for Covid

Anesthesiologist group: stop taking Ozempic before surgery

FDA approves RSV monoclonal antibody for infants, toddlers

Cancer drug shortages should be causing more outrage

Life science postdocs should get big pay hike, NIH panel says

New air purifier tech could be key to improving indoor air quality

Profiling embryos to choose those with higher IQs is almost a reality

explore

How Medicaid coverage policies for immigrants impact new moms

As digital health tech proliferates, a new institute aims to cut through hype

STAT Virtual Event: The State of Biosimilars: What to Watch

Startup Neumora takes a novel depression drug to Phase 3

AI can’t replace a physician’s gut feeling

Detailed data confirm benefits, risks of Eli Lilly's Alzheimer's drug

entertainment

knowledge

entertainment

hotspot